The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 07, 2014
Filed:
May. 12, 2010
Xi Chen, Palo Alto, CA (US);
Dean R. Dragoli, Los Altos, CA (US);
Pingchen Fan, Fremont, CA (US);
Mark M. Gleason, Redwood City, CA (US);
Juan C. Jaen, Burlingame, CA (US);
Lianfa LI, Palo Alto, CA (US);
Jeffrey P. Mcmahon, Mountain View, CA (US);
Jay Powers, Pacifica, CA (US);
Yibin Zeng, Foster City, CA (US);
Penglie Zhang, Foster City, CA (US);
Junfa Fan, Foster City, CA (US);
Xi Chen, Palo Alto, CA (US);
Dean R. Dragoli, Los Altos, CA (US);
Pingchen Fan, Fremont, CA (US);
Mark M. Gleason, Redwood City, CA (US);
Juan C. Jaen, Burlingame, CA (US);
Lianfa Li, Palo Alto, CA (US);
Jeffrey P. McMahon, Mountain View, CA (US);
Jay Powers, Pacifica, CA (US);
Yibin Zeng, Foster City, CA (US);
Penglie Zhang, Foster City, CA (US);
Junfa Fan, Foster City, CA (US);
ChemoCentryx, Inc., Mountain View, CA (US);
Abstract
Compounds having formula I, or pharmaceutically acceptable salts, hydrates or N-oxides thereof are provided and are useful for binding to CXCR7, and treating diseases that are dependent, at least in part, on CXCR7 activity. Accordingly, the present invention provides in further aspects, compositions containing one or more of the above-noted compounds in admixture with a pharmaceutically acceptable excipient.